Schedule 13G ownership disclosure

Forma Therapeutics Holdings, Inc.,

Security class unavailable · CUSIP: 34633R104

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,860,653
Percent of class
6.0300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-22-017582
Form type
SC 13G
Filer
Forma Therapeutics Holdings, Inc.
CIK
CIK 1538927
Filed
Feb 10, 2022
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub